搜索临床试验以:Glucagon-Like Peptide-1 (GLP-1) agonists
总计58877个结果
-
LENZ Therapeutics, IncORA, Inc.完全的
-
Tel Aviv UniversityZohar Landau; Shani Tsameret未知
-
Icahn School of Medicine at Mount Sinai完全的
-
Pathalys PharmaLaunch Therapeutics招聘中
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
University of Colorado, DenverNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)主动,不招人
-
Hassane M. Zarour, MDNational Cancer Institute (NCI)完全的
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Merck Sharp & Dohme...终止
-
Jeppe SkovNovo Nordisk A/S完全的
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的
-
Mount Sinai Hospital, CanadaNovo Nordisk A/S完全的
-
Signe TorekovKarolinska Institutet; Rigshospitalet, Denmark; University of Leeds; Holbaek Sygehus招聘中
-
Novo Nordisk A/S主动,不招人肥胖美国, 捷克语, 德国, 加拿大, 匈牙利, 葡萄牙, 挪威, 南非, 波兰, 希腊, 保加利亚, 斯洛伐克
-
Zuyderland Medisch CentrumNederlandse Obestias Kliniek (NOK)尚未招聘肥胖 | 肥胖,病态 | 体重增加
-
Novo Nordisk A/S完全的
-
Nanjing First Hospital, Nanjing Medical University未知
-
Haruhiko FukudaMinistry of Health, Labour and Welfare, Japan完全的